Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia.

Watts EL. et al, (2022), Int J Cancer

Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.

Cairat M. et al, (2022), BMC Med, 20

Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.

Robinson N. et al, (2022), Br J Cancer

Erratum: Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research (JNCI: J Natl Cancer Inst (2021) 113: 6 (727-734) DOI: 10.1093/jnci/djaa154)

Hurwitz LM. et al, (2022), Journal of the National Cancer Institute, 114

Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants.

Watling CZ. et al, (2022), BMC Med, 20

Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case-Control Study and Meta-analysis.

Harbs J. et al, (2022), Cancer Epidemiol Biomarkers Prev

Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.

Mukama T. et al, (2022), Br J Cancer

Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.

Bouras E. et al, (2022), BMC Med, 20

The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study.

Ioannidou A. et al, (2022), PLoS Med, 19

Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.

His M. et al, (2021), BMC Med, 19

Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study.

Papier K. et al, (2021), Eur J Epidemiol

Blood biomarker levels by total sleep duration: cross-sectional analyses in UK Biobank.

Wong TY. et al, (2021), Sleep Med, 88, 256 - 261

A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer

Jermusyk A. et al, (2021), American Journal of Human Genetics, 108, 1852 - 1865

Evaluation of protein and amino acid intake estimates from the EPIC dietary questionnaires and 24-h dietary recalls using different food composition databases.

Iguacel I. et al, (2021), Nutr Metab Cardiovasc Dis

A New Pipeline for the Normalization and Pooling of Metabolomics Data.

Viallon V. et al, (2021), Metabolites, 11

Physical activity in relation to circulating hormone concentrations in 117,100 men in UK Biobank.

Watts EL. et al, (2021), Cancer Causes Control

Associations of circulating insulin-like growth factor-I with intake of dietary proteins and other macronutrients.

Watling CZ. et al, (2021), Clin Nutr, 40, 4685 - 4693

Prospective analysis of circulating metabolites and endometrial cancer risk.

Dossus L. et al, (2021), Gynecol Oncol

Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.

Kliemann N. et al, (2021), BMC Med, 19

KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.

Lin H-Y. et al, (2021), Sci Rep, 11

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?